GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

The Accelerating Kids' Access to Care Act would expand Medicaid access for pediatric patients so that it covers interventional cardiologists outside of their home states.

Flood damage forced Baxter to close a facility that makes 60% of IV solutions in the U.S., a loss of 1.5 million bags per day. 

The suit, which includes multiple accusations of malpractice and dishonest behavior, is just the latest chapter of a story that has been making headlines for years. 

LVOT obstruction remains a significant complication of TMVR, making the long-term safety and effectiveness of the LAMPOON technique a hot topic in interventional cardiology.

“Unlike expensive pharmaceuticals like Ozempic, which require lifetime use, time-restricted eating is a simple lifestyle change that does not cause side effects and can be maintained indefinitely,” one doctor explained. 

Older cancer survivors appear to face higher risks of stroke, heart attack and heart failure. Early screening and preventative measures can help.